XML 55 R44.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
SEGMENT INFORMATION (Tables)
6 Months Ended
Apr. 30, 2024
Segment Reporting [Abstract]  
Segment Profitability and Segment Assets
The profitability of each of the segments is measured after excluding items such as transformational initiatives, acquisition and integration costs, amortization of intangible assets related to business combinations, interest income, interest expense and other items as noted in the reconciliations below:
Three Months EndedSix Months Ended
 April 30,April 30,
 2024202320242023
 (in millions)
Net Revenue:
Life Sciences and Applied Markets$754 $874 $1,600 $1,817 
Diagnostics and Genomics417 456 824 888 
Agilent CrossLab402 387 807 768 
Total net revenue$1,573 $1,717 $3,231 $3,473 
Segment Income From Operations:
Life Sciences and Applied Markets$186 $244 $422 $544 
Diagnostics and Genomics86 93 156 166 
Agilent CrossLab123 103 245 206 
Total segment income from operations$395 $440 $823 $916 
The following table reflects segment and unallocated assets. Segment assets include allocations of corporate assets, goodwill, net other intangibles and other assets. Unallocated assets primarily consist of cash, cash equivalents, short-term and long-term investments, deferred tax assets, right-of-use assets and other assets.  
 April 30,
2024
October 31,
2023
(in millions)
Assets:  
Life Sciences and Applied Markets$3,096 $3,161 
Diagnostics and Genomics3,978 3,966 
Agilent CrossLab925 897 
Unallocated Assets2,857 2,739 
Total assets$10,856 $10,763 
Reconciliation of segment results to total enterprise results
The following table reconciles segment income from operations to Agilent’s total enterprise income before taxes: 
Three Months EndedSix Months Ended
 April 30,April 30,
 2024202320242023
 (in millions)
Total segment income from operations$395 $440 $823 $916 
Unallocated costs:
Amortization of intangible assets related to business combinations(26)(38)(52)(74)
Acquisition and integration costs(5)(1)(7)
Transformational initiatives(1)(5)(4)(12)
Asset impairment— — (8)— 
Change in fair value of contingent consideration— — — (1)
Restructuring and other related costs(1)— (4)— 
Other(5)(9)(7)(13)
Total unallocated costs(32)(57)(76)(107)
Income from operations363 383 747 809 
Interest income19 12 37 21 
Interest expense(20)(24)(42)(49)
Other income (expense), net (1)
12 35 
Income before taxes, as reported$374 $377 $777 $787 
(1) For the six months ended April 30, 2024, other income (expense), net includes primarily income related to foreign currency translation reclassified out of accumulated comprehensive income (loss) and the defined benefit retirement and post-retirement benefit plans.